Pernille Laerkegaard Hansen

Company: AstraZeneca

Job title: Executive Director & Head of Bioscience & Renal

Seminars:

Advancing CKD Drug Discovery to Develop Distinctive Therapies with Substantial Clinical Impact in a Dynamic Market Landscape 9:30 am

Explore the limitations of current therapies and identify patient populations and disease mechanisms that remain underserved, paving the way for next-generation innovations Discover strategies to design and position novel treatments that offer clear advantages over existing options, including improved efficacy, safety, and patient outcomes Gain insights into drug design and trial planning in the context…Read more

day: Day One AM

Fireside Chat: Navigating the Multi-Drug Treatment Landscape in CKD: Understanding the Implications on Drug Discovery & Development to Inform Future Directions 8:00 am

As the chronic kidney disease treatment landscape evolves, marked by significant breakthroughs such as SGLT2i, GLP-1s, ACEi/ARBs, MRAs, the field is rapidly advancing toward more effective multi-drug therapies. However, these advancements present new challenges and considerations for drug discovery, development, and clinical trial design. This panel will explore the complexities of leveraging these successes to…Read more

day: Day One AM